{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:44:04Z","timestamp":1792467844644,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032408","name":"Ardelyx","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032408","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jrnjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1053\/j.jrn.2024.07.003","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T13:17:17Z","timestamp":1720531037000},"page":"25-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Tenapanor: A Phosphate Absorption Inhibitor for the Management of Hyperphosphatemia in Patients With Kidney Failure"],"prefix":"10.1053","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1528-8161","authenticated-orcid":false,"given":"Kathleen M.","family":"Hill Gallant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart M.","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7243-6475","authenticated-orcid":false,"given":"Kenji","family":"Kozuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Edelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn M.","family":"Chertow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2024.07.003_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100584","article-title":"Serum phosphorus level rises in US hemodialysis patients over the past decade: a DOPPS special report","volume":"5","author":"Guedes","year":"2023","journal-title":"Kidney Med"},{"key":"10.1053\/j.jrn.2024.07.003_bib4","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.18632\/aging.100948","article-title":"Accelerated ageing and renal dysfunction links lower socioeconomic status and dietary phosphate intake","volume":"8","author":"McClelland","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"10.1053\/j.jrn.2024.07.003_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1053\/j.ajkd.2012.11.051","article-title":"Chronic kidney disease: a clinical model of premature aging","volume":"62","author":"Stenvinkel","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2024.07.003_bib6","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2024.07.003_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074996","article-title":"Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study","volume":"8","author":"McGovern","year":"2013","journal-title":"PLoS One"},{"key":"10.1053\/j.jrn.2024.07.003_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3945\/ajcn.112.053934","article-title":"Public health impact of dietary phosphorus excess on bone and cardiovascular health in the general population","volume":"98","author":"Calvo","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.jrn.2024.07.003_bib9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3945\/ajcn.113.073148","article-title":"High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III","volume":"99","author":"Chang","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.jrn.2024.07.003_bib10","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.167.9.879","article-title":"Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community","volume":"167","author":"Dhingra","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.jrn.2024.07.003_bib12","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3390\/nu10101364","article-title":"Intestinal phosphorus absorption in chronic kidney disease","volume":"10","author":"Stremke","year":"2018","journal-title":"Nutrients"},{"key":"10.1053\/j.jrn.2024.07.003_bib13","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2215\/CJN.09750913","article-title":"Renal control of calcium, phosphate, and magnesium homeostasis","volume":"10","author":"Blaine","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2024.07.003_bib14","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s40265-018-0950-2","article-title":"Targeting gastrointestinal transport proteins to control hyperphosphatemia in chronic kidney disease","volume":"78","author":"Fouque","year":"2018","journal-title":"Drugs"},{"key":"10.1053\/j.jrn.2024.07.003_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.jrn.2020.02.003","article-title":"Management of hyperphosphatemia in end-stage renal disease: a new paradigm","volume":"31","author":"Rastogi","year":"2021","journal-title":"J Ren Nutr"},{"key":"10.1053\/j.jrn.2024.07.003_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/1687-9856-2009-496514","article-title":"Fibroblast growth factor 23 (FGF23) and disorders of phosphate metabolism","volume":"2009","author":"Saito","year":"2009","journal-title":"Int J Pediatr Endocrinol"},{"key":"10.1053\/j.jrn.2024.07.003_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ki.2008.130","article-title":"Hyperphosphatemia of chronic kidney disease","volume":"74","author":"Hruska","year":"2008","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2024.07.003_bib18","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.3390\/nu13072249","article-title":"Trends in total, added, and natural phosphorus intake in adult Americans, NHANES 1988-1994 to NHANES 2015-2016","volume":"13","author":"Fulgoni","year":"2021","journal-title":"Nutrients"},{"key":"10.1053\/j.jrn.2024.07.003_bib19","series-title":"Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride","article-title":"The National Academies Collection: reports funded by National Institutes of health","year":"1997"},{"key":"10.1053\/j.jrn.2024.07.003_bib20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.ackd.2012.10.008","article-title":"Sodium- and phosphorus-based food additives: persistent but surmountable hurdles in the management of nutrition in chronic kidney disease","volume":"20","author":"Guti\u00e9rrez","year":"2013","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1053\/j.jrn.2024.07.003_bib21","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1053\/j.ajkd.2018.11.004","article-title":"Dietary phosphate and the forgotten kidney patient: a critical need for FDA regulatory action","volume":"73","author":"Calvo","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2024.07.003_bib22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/j.jrn.2012.12.003","article-title":"The prevalence of phosphorus-containing food additives in top-selling foods in grocery stores","volume":"23","author":"L\u00e9on","year":"2013","journal-title":"J Ren Nutr"},{"key":"10.1053\/j.jrn.2024.07.003_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/j.jrn.2013.09.003","article-title":"Contribution of food additives to sodium and phosphorus content of diets rich in processed foods","volume":"24","author":"Carrigan","year":"2014","journal-title":"J Ren Nutr"},{"key":"10.1053\/j.jrn.2024.07.003_bib24","first-page":"1","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD)","volume":"71","year":"2017","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.jrn.2024.07.003_bib25","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2024.07.003_bib26","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2215\/CJN.04620510","article-title":"Prescribed dietary phosphate restriction and survival among hemodialysis patients","volume":"6","author":"Lynch","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2024.07.003_bib27","first-page":"1","article-title":"A new age for phosphate management: novel, non-binder therapies to combat diets high in hidden phosphates","volume":"7","author":"Clegg","year":"2022","journal-title":"Nephrol Renal Dis"},{"key":"10.1053\/j.jrn.2024.07.003_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100437","article-title":"The impact of phosphorus management today on quality of life: patient perspectives","volume":"4","author":"Forfang","year":"2022","journal-title":"Kidney Med"},{"key":"10.1053\/j.jrn.2024.07.003_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.jrn.2016.09.007","article-title":"Phosphate-containing prescription medications contribute to the daily phosphate intake in a third of hemodialysis patients","volume":"27","author":"Nelson","year":"2017","journal-title":"J Ren Nutr"},{"key":"10.1053\/j.jrn.2024.07.003_bib30","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/ki.2015.67","article-title":"A dearth of data: the problem of phosphorus in prescription medications","volume":"87","author":"Sherman","year":"2015","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2024.07.003_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5414\/CN109853","article-title":"Phosphates in medications: impact on dialysis patients","volume":"93","author":"Sawin","year":"2020","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.jrn.2024.07.003_bib32","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1159\/000518110","article-title":"Small intestinal phosphate absorption: novel therapeutic implications","volume":"52","author":"Yee","year":"2021","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.jrn.2024.07.003_bib33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/MNH.0000000000000719","article-title":"Intestinal phosphorus absorption: recent findings in translational and clinical research","volume":"30","author":"Hill Gallant","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1053\/j.jrn.2024.07.003_bib34","first-page":"G756","article-title":"Regulation of small intestinal Na-P(i) type IIb cotransporter by dietary phosphate intake","volume":"277","author":"Hattenhauer","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1053\/j.jrn.2024.07.003_bib35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1042\/bj3430705","article-title":"Regulation of intestinal Na+-dependent phosphate co-transporters by a low-phosphate diet and 1,25-dihydroxyvitamin D3","volume":"343","author":"Katai","year":"1999","journal-title":"Biochem J"},{"key":"10.1053\/j.jrn.2024.07.003_bib36","doi-asserted-by":"crossref","first-page":"F39","DOI":"10.1152\/ajprenal.00375.2003","article-title":"Intestinal Na-P(i) cotransporter adaptation to dietary P(i) content in vitamin D receptor null mice","volume":"287","author":"Segawa","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.jrn.2024.07.003_bib37","first-page":"G90","article-title":"Phosphate transport across rat jejunum: influence of sodium, pH, and 1,25-dihydroxyvitamin D3","volume":"251","author":"Lee","year":"1986","journal-title":"Am J Physiol"},{"key":"10.1053\/j.jrn.2024.07.003_bib38","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1681\/ASN.2009050559","article-title":"Intestinal npt2b plays a major role in phosphate absorption and homeostasis","volume":"20","author":"Sabbagh","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2024.07.003_bib39","doi-asserted-by":"crossref","first-page":"F1105","DOI":"10.1152\/ajprenal.00663.2010","article-title":"Inorganic phosphate homeostasis in sodium-dependent phosphate cotransporter Npt2b(+)\/(-) mice","volume":"301","author":"Ohi","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.jrn.2024.07.003_bib40","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1113\/expphysiol.2005.032516","article-title":"Intestinal phosphate absorption and the effect of vitamin D: a comparison of rats with mice","volume":"91","author":"Marks","year":"2006","journal-title":"Exp Physiol"},{"key":"10.1053\/j.jrn.2024.07.003_bib41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jbmr.3894","article-title":"Kidney disease progression does not decrease intestinal phosphorus absorption in a rat model of chronic kidney disease-mineral bone disorder","volume":"35","author":"Vorland","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.jrn.2024.07.003_bib42","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12281","article-title":"Experimental and regional variations in Na+-dependent and Na+-independent phosphate transport along the rat small intestine and colon","volume":"3","author":"Marks","year":"2015","journal-title":"Physiol Rep"},{"key":"10.1053\/j.jrn.2024.07.003_bib43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1042\/cs0560407","article-title":"Absorption of inorganic phosphate in the human small intestine","volume":"56","author":"Walton","year":"1979","journal-title":"Clin Sci (Lond)"},{"key":"10.1053\/j.jrn.2024.07.003_bib44","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/0016-5085(83)90443-2","article-title":"Absorption of phosphate in the jejunum of patients with chronic renal failure before and after correction of vitamin D deficiency","volume":"85","author":"Davis","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1053\/j.jrn.2024.07.003_bib45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ekir.2017.08.003","article-title":"NPT-IIb inhibition does not improve hyperphosphatemia in CKD","volume":"3","author":"Larsson","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1053\/j.jrn.2024.07.003_bib46","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ekir.2020.12.017","article-title":"NaPi-IIb inhibition for hyperphosphatemia in CKD hemodialysis patients","volume":"6","author":"Maruyama","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1053\/j.jrn.2024.07.003_bib47","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1681\/ASN.2020091340","article-title":"Intestinal phosphorus absorption in moderate CKD and healthy adults determined using a radioisotopic tracer","volume":"32","author":"Stremke","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2024.07.003_bib48","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3177\/jnsv.66.60","article-title":"Significant species differences in intestinal phosphate absorption between dogs, rats, and monkeys","volume":"66","author":"Ichida","year":"2020","journal-title":"J Nutr Sci Vitaminol"},{"key":"10.1053\/j.jrn.2024.07.003_bib49","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.kint.2020.09.035","article-title":"EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients","volume":"99","author":"Hill Gallant","year":"2021","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2024.07.003_bib50","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ekir.2019.06.002","article-title":"Strategies for phosphate control in patients with CKD","volume":"4","author":"Barreto","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1053\/j.jrn.2024.07.003_bib51","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.semnephrol.2012.12.018","article-title":"Management of natural and added dietary phosphorus burden in kidney disease","volume":"33","author":"Cupisti","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1053\/j.jrn.2024.07.003_bib52","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3109\/0886022X.2012.718724","article-title":"The adequacy of phosphorus binder prescriptions among American hemodialysis patients","volume":"34","author":"Huml","year":"2012","journal-title":"Ren Fail"},{"key":"10.1053\/j.jrn.2024.07.003_bib53","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1021\/acsmedchemlett.2c00037","article-title":"Discovery of tenapanor: a first-in-class minimally systemic inhibitor of intestinal Na(+)\/H(+) exchanger isoform 3","volume":"13","author":"Jacobs","year":"2022","journal-title":"ACS Med Chem Lett"},{"key":"10.1053\/j.jrn.2024.07.003_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam6474","article-title":"Inhibition of sodium\/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability","volume":"10","author":"King","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1053\/j.jrn.2024.07.003_bib55","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1681\/ASN.2014030317","article-title":"Gastrointestinal inhibition of sodium-hydrogen exchanger 3 reduces phosphorus absorption and protects against vascular calcification in CKD","volume":"26","author":"Labont\u00e9","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2024.07.003_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007790","article-title":"Intestinal inhibition of the Na+\/H+ exchanger 3 prevents cardiorenal damage in rats and inhibits Na+ uptake in humans","volume":"6","author":"Spencer","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1053\/j.jrn.2024.07.003_bib57","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/IJNRD.S334024","article-title":"Novel treatments from inhibition of the intestinal sodium-hydrogen exchanger 3","volume":"14","author":"Kovesdy","year":"2021","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1053\/j.jrn.2024.07.003_bib58","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/969","article-title":"Renal and intestinal absorptive defects in mice lacking the NHE3 Na+\/H+ exchanger","volume":"19","author":"Schultheis","year":"1998","journal-title":"Nat Genet"},{"issue":"part 1","key":"10.1053\/j.jrn.2024.07.003_bib59","first-page":"G29","article-title":"NHE2 and NHE3 are human and rabbit intestinal brush-border proteins","volume":"270","author":"Hoogerwerf","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1053\/j.jrn.2024.07.003_bib60","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.34067\/KID.0002002021","article-title":"Safety and efficacy of tenapanor for long-term serum phosphate control in maintenance dialysis: a 52-week randomized phase 3 trial (PHREEDOM)","volume":"2","author":"Block","year":"2021","journal-title":"Kidney360"},{"key":"10.1053\/j.jrn.2024.07.003_bib61","series-title":"XPHOZAH\u00ae prescribing information","year":"2023"},{"key":"10.1053\/j.jrn.2024.07.003_bib62","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1681\/ASN.2016080855","article-title":"Effect of tenapanor on serum phosphate in patients receiving hemodialysis","volume":"28","author":"Block","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2024.07.003_bib63","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1681\/ASN.2018080832","article-title":"Efficacy and safety of tenapanor in patients with hyperphosphatemia receiving maintenance hemodialysis: a randomized phase 3 trial","volume":"30","author":"Block","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2024.07.003_bib64","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.34067\/KID.0000000000000280","article-title":"Tenapanor improves long-term control of hyperphosphatemia in patients receiving maintenance dialysis: the NORMALIZE study","volume":"4","author":"Silva","year":"2023","journal-title":"Kidney360"},{"key":"10.1053\/j.jrn.2024.07.003_bib65","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1681\/ASN.2020101398","article-title":"A randomized trial of tenapanor and phosphate binders as a dual-mechanism treatment for hyperphosphatemia in patients on maintenance dialysis (AMPLIFY)","volume":"32","author":"Pergola","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2024.07.003_bib66","doi-asserted-by":"crossref","first-page":"732","DOI":"10.34067\/KID.0000000000000387","article-title":"Tenapanor as therapy for hyperphosphatemia in maintenance dialysis patients: results from the OPTIMIZE study","volume":"5","author":"Sprague","year":"2024","journal-title":"Kidney360"},{"key":"10.1053\/j.jrn.2024.07.003_bib67","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/nep.13243","article-title":"Gastrointestinal symptoms in patients receiving dialysis: a systematic review","volume":"23","author":"Zuvela","year":"2018","journal-title":"Nephrology"},{"key":"10.1053\/j.jrn.2024.07.003_bib68","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.ekir.2021.05.012","article-title":"Phosphate balance and CKD-mineral bone disease","volume":"6","author":"Sprague","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1053\/j.jrn.2024.07.003_bib69","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1093\/ndt\/gft280","article-title":"Serum phosphorus levels and pill burden are inversely associated with adherence in patients on hemodialysis","volume":"29","author":"Wang","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2024.07.003_bib70","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2215\/CJN.00290109","article-title":"Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients","volume":"4","author":"Chiu","year":"2009","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227624001560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227624001560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:39:42Z","timestamp":1791412782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051227624001560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1051227624001560"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2024.07.003","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tenapanor: A Phosphate Absorption Inhibitor for the Management of Hyperphosphatemia in Patients With Kidney Failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Renal Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jrn.2024.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}